|
|
| Product Name: | LHRH | | Synonyms: | gly(10)-lhr;PYROGLU-HIS-TRP-SER-TYR-GLY-LEU-ARG-PRO-GLY;PYR-HIS-TRP-SER-TYR-GLY-LEU-ARG-PRO-GLY;PYR-HIS-TRP-SER-TYR-GLY-LEU-ARG-PRO-GLY-OH;PYR-HWSYGLRPG;PGLU-HIS-TRP-SER-TYR-GLY-LEU-ARG-PRO-GLY;[PYR]HWSYGLRPG-OH;LUTEINIZING HORMONE-RELEASING HORMONE (LH-RH), HUMAN | | CAS: | 35263-73-1 | | MF: | C55H74N16O14 | | MW: | 1183.28 | | EINECS: | | | Product Categories: | peptide | | Mol File: | 35263-73-1.mol |  |
| density | 1.54±0.1 g/cm3(Predicted) | | storage temp. | −20°C | | pka | 3.67±0.10(Predicted) | | form | Solid | | color | White to off-white | | Sequence | {Pyr}-His-Trp-Ser-Tyr-Gly-Leu-Arg-Pro-Gly |
| Uses | LHRH (free acid), the luteinizing hormone-releasing hormone, is a neuropeptide hypothalamic. LHRH regulates reproduction. LHRH can be used for the research of cancer[1]. | | References | [1] Schally AV, et, al. Discovery of LHRH and development of LHRH analogs for prostate cancer treatment. Prostate. 2017 Jun;77(9):1036-1054. DOI:10.1002/pros.23360
[2] Pearce TR, et, al. Peptide targeted lipid nanoparticles for anticancer drug delivery. Adv Mater. 2012 Jul 24;24(28):3803-22, 3710. DOI:10.1002/adma.201200832 |
| | LHRH Preparation Products And Raw materials |
|